Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100PNC2
Period2021-01-01 → 2021-12-31
Filed2022-11-17
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amends S100NSY7. Amended by S100PNM1 (2022-11-17).

Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥642m2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥314m2020-01-01 → 2020-12-31StandaloneNet sales
Revenue¥1.3bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥169m2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Revenue¥229m2017-01-01 → 2017-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOperating income
Operating income−¥1.7bn2020-01-01 → 2020-12-31StandaloneOperating income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥1.7bn2020-01-01 → 2020-12-31StandaloneOrdinary income
Ordinary income−¥539m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.2bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.1bn2017-01-01 → 2017-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.6bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Profit before tax−¥2.1bn2020-01-01 → 2020-12-31StandaloneIncome before income taxes
Net income−¥1.6bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥2.1bn2020-01-01 → 2020-12-31StandaloneProfit loss
Net income−¥912m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.1bn2017-01-01 → 2017-12-31dStandaloneNet income loss (5-year summary)
Total assets¥4.3bnat 2021-12-31StandaloneAssets
Total assets¥2.8bnat 2020-12-31StandaloneAssets
Total assets¥4.4bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥3.4bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total assets¥3.5bnat 2017-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥698mat 2021-12-31StandaloneLiabilities
Total liabilities¥793mat 2020-12-31StandaloneLiabilities
Net assets / equity¥3.6bnat 2021-12-31StandaloneNet assets
Net assets / equity¥2.0bnat 2020-12-31StandaloneNet assets
Net assets / equity¥3.5bnat 2019-12-31dStandaloneNet assets
Net assets / equity¥2.9bnat 2018-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.9bnat 2017-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.5bnat 2021-12-31StandaloneCash and deposits
Cash and deposits¥2.1bnat 2020-12-31StandaloneCash and deposits
Cash & equivalents¥3.2bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2020-12-31StandaloneCash and cash equivalents
Cash & equivalents¥3.1bnat 2019-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.9bnat 2017-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.5bn2020-01-01 → 2020-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥238m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.1bn2017-01-01 → 2017-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥942,0002021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥38m2020-01-01 → 2020-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥4m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥342m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥132m2017-01-01 → 2017-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥242m2020-01-01 → 2020-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2017-01-01 → 2017-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-145.582020-01-01 → 2020-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-65.552019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-104.552018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-106.232017-01-01 → 2017-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥206.86at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥136.43at 2020-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥240.71at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥216.61at 2018-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥263.54at 2017-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio83.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.4%at 2020-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.9%at 2017-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued14,641,900at 2020-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued14,331,300at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued13,346,000at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,086,000at 2017-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees33at 2021-12-31StandaloneNumber of employees
Employees32at 2020-12-31StandaloneNumber of employees
Employees27at 2019-12-31dStandaloneNumber of employees
Employees30at 2018-12-31dStandaloneNumber of employees
Employees29at 2017-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 864
ItemContextValueUnit
Payments of long term loans receivable inv cfPrior1YearDuration_NonConsolidatedMember-21762000JPY
Payments of long term loans receivable inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Payments for lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember-2346000JPY
Payments for lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember-71000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember80000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-37577000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-942000JPY
Proceeds from long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember100000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember100000000JPY
Repayment of long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember-100000000JPY
Repayment of long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember-122232000JPY
Repayments of lease obligations fin cfPrior1YearDuration_NonConsolidatedMember-3147000JPY
Repayments of lease obligations fin cfCurrentYearDuration_NonConsolidatedMember-2609000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember245505000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember3085424000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember42902000JPY
Purchase of treasury stock fin cfPrior1YearDuration_NonConsolidatedMember-95000JPY
Purchase of treasury stock fin cfCurrentYearDuration_NonConsolidatedMember-36000JPY
Other payments fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Other payments fin cfCurrentYearDuration_NonConsolidatedMember-12065000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember242261000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember3091384000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-14147000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember38171000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-1274664000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember1386785000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember3097514000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1822850000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1822850000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember3209635000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember348523000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember174159000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember242284000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember303877000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember987242000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember825474000JPY
Business consignment expenses sgaPrior1YearDuration_NonConsolidatedMember63736000JPY
Business consignment expenses sgaCurrentYearDuration_NonConsolidatedMember69446000JPY
Taxes and dues sgaPrior1YearDuration_NonConsolidatedMember81221000JPY
Taxes and dues sgaCurrentYearDuration_NonConsolidatedMember101945000JPY
License fee sgaPrior1YearDuration_NonConsolidatedMember50610000JPY
License fee sgaCurrentYearDuration_NonConsolidatedMember32916000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember987242000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember825474000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書(2022年11月17日付け訂正報告書の添付インラインXBRL)
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-03-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2020-12-31pass rounding
balance sheet identitynon_consolidated 2021-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2019-12-31pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2020-01-01/2020-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2020-01-01/2020-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · total assetsnon_consolidated 2020-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass